{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:14:08Z","timestamp":1793070848748,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.humpath.2022.09.001","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T11:51:59Z","timestamp":1663156319000},"page":"123-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: cysts, angiomyolipomas, and renal cell carcinoma"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5163-6955","authenticated-orcid":false,"given":"Sounak","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa L.","family":"Stanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan P.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumeal D.","family":"Whaley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren","family":"Herrera-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael E.","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Cheville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2022.09.001_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","article-title":"mTOR at the nexus of nutrition, growth, ageing and disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.humpath.2022.09.001_bib2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molcel.2012.06.009","article-title":"TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1","volume":"47","author":"Dibble","year":"2012","journal-title":"Mol Cell"},{"key":"10.1016\/j.humpath.2022.09.001_bib3","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.eururo.2018.06.007","article-title":"Somatic Bi-allelic loss of TSC genes in eosinophilic solid and cystic renal cell carcinoma","volume":"74","author":"Mehra","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2022.09.001_bib4","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/hmg\/6.12.2155","article-title":"Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis","volume":"6","author":"Jones","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.humpath.2022.09.001_bib5","article-title":"Tuberous sclerosis complex","volume":"2","author":"Henske","year":"2016","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.humpath.2022.09.001_bib6","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3389\/fneur.2020.00972","article-title":"Renal manifestations of tuberous sclerosis complex: key findings from the final analysis of the TOSCA study focussing mainly on renal angiomyolipomas","volume":"11","author":"Kingswood","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.humpath.2022.09.001_bib7","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","article-title":"Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors","volume":"70","author":"Rakowski","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.humpath.2022.09.001_bib8","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000248","article-title":"Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients","volume":"38","author":"Guo","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib9","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/PAS.0000000000000237","article-title":"Renal cell carcinoma in tuberous sclerosis complex","volume":"38","author":"Yang","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib10","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.mayocp.2020.11.004","article-title":"Renal neoplasia in tuberous sclerosis: a study of 41 patients","volume":"96","author":"Gupta","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.humpath.2022.09.001_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1148\/58.1.1","article-title":"The osseous lesions of tuberous sclerosis","volume":"58","author":"Holt","year":"1952","journal-title":"Radiology"},{"key":"10.1016\/j.humpath.2022.09.001_bib12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/PAS.0000000000001422","article-title":"\"Renal cell carcinoma with leiomyomatous stroma\" harbor somatic mutations of TSC1, TSC2, MTOR, and\/or ELOC (TCEB1): clinicopathologic and molecular characterization of 18 sporadic tumors supports a distinct entity","volume":"44","author":"Shah","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib13","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41379-021-00737-6","article-title":"Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/PAP.0000000000000337","article-title":"Renal cell carcinoma with fibromyomatous stroma-the whole story","volume":"29","author":"Shah","year":"2022","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/his.13865","article-title":"Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity?","volume":"75","author":"Trpkov","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.09.001_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2021.04.013","article-title":"Low-Grade Oncocytic Tumor of Kidney (CK7-Positive, CD117-Negative): incidence in a single institutional experience with clinicopathological and molecular characteristics","volume":"114","author":"Kravtsov","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib17","article-title":"Low-grade oncocytic tumour expands the spectrum of renal oncocytic tumours and deserves separate classification: a review of 23 cases from a single tertiary institute","author":"Akgul","year":"2021","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00428-020-02927-0","article-title":"Characterization of a distinct low-grade oncocytic renal tumor (CD117-negative and cytokeratin 7-positive) based on a tertiary oncology center experience: the new evidence from China","volume":"478","author":"Guo","year":"2021","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2022.09.001_bib19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.humpath.2020.12.006","article-title":"TSC\/MTOR-mutated eosinophilic renal tumors are a distinct entity that is CK7+\/CK20-\/vimentin-: a validation study","volume":"115","author":"Tjota","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41379-021-00896-6","article-title":"Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney","volume":"35","author":"Kapur","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib21","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s41379-021-00906-7","article-title":"Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1","volume":"35","author":"Morini","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41379-021-00969-6","article-title":"Oncocytic renal neoplasms with diffuse keratin 7 immunohistochemistry harbor frequent alterations in the mammalian target of rapamycin pathway","volume":"35","author":"Mohanty","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0022-5347(17)43234-4","article-title":"Renal lesions in tuberous sclerosis","volume":"138","author":"Stillwell","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2022.09.001_bib24","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","article-title":"Causes of death in patients with tuberous sclerosis","volume":"66","author":"Shepherd","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.humpath.2022.09.001_bib25","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/ki.2008.485","article-title":"Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1\/TSC2 contiguous gene syndrome","volume":"74","author":"Consugar","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.humpath.2022.09.001_bib26","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1086\/514888","article-title":"Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene","volume":"61","author":"Sampson","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.humpath.2022.09.001_bib27","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1600-6143.2007.02030.x","article-title":"Mosaicism in autosomal dominant polycystic kidney disease revealed by genetic testing to enable living related renal transplantation","volume":"8","author":"Connor","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.humpath.2022.09.001_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.eururo.2021.11.013","volume":"81","author":"Gupta","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2022.09.001_bib29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.urology.2009.02.078","article-title":"Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure","volume":"74","author":"Hajj","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.humpath.2022.09.001_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000351049","article-title":"Autosomal dominant polycystic kidney disease: prevalence of renal neoplasias in surgical kidney specimens","volume":"123","author":"Jilg","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.humpath.2022.09.001_bib31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.eururo.2021.11.013","article-title":"Renal neoplasia in polycystic kidney disease: an assessment of tuberous sclerosis complex-associated renal neoplasia and PKD1\/TSC2 contiguous gene deletion syndrome","volume":"81","author":"Gupta","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2022.09.001_bib32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1464-410X.1994.tb16577.x","article-title":"A population study of renal disease in patients with tuberous sclerosis","volume":"74","author":"Webb","year":"1994","journal-title":"Br J Urol"},{"key":"10.1016\/j.humpath.2022.09.001_bib33","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1464-410X.2004.05046.x","article-title":"An epidemiological study of renal pathology in tuberous sclerosis complex","volume":"94","author":"O'Callaghan","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.humpath.2022.09.001_bib34","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/jmg.33.6.480","article-title":"A cross sectional study of renal involvement in tuberous sclerosis","volume":"33","author":"Cook","year":"1996","journal-title":"J Med Genet"},{"key":"10.1016\/j.humpath.2022.09.001_bib35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/316951","article-title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs","volume":"68","author":"Dabora","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.humpath.2022.09.001_bib36","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1086\/302381","article-title":"Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis","volume":"64","author":"Jones","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.humpath.2022.09.001_bib37","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.urology.2007.07.045","article-title":"The role of partial nephrectomy for the management of sporadic renal angiomyolipoma","volume":"70","author":"Boorjian","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.humpath.2022.09.001_bib38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2022.09.001_bib39","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.humpath.2022.09.001_bib40","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2015.05.016","article-title":"Long-term follow-up assessing renal angiomyolipoma treatment patterns, morbidity, and mortality: an observational study in tuberous sclerosis complex patients in The Netherlands","volume":"66","author":"Eijkemans","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.humpath.2022.09.001_bib41","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/JU.0000000000001065","article-title":"Sporadic angiomyolipomas growth kinetics while on everolimus: results of a phase II trial","volume":"204","author":"Geynisman","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2022.09.001_bib42","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/modpathol.2011.136","article-title":"Cathepsin K expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney","volume":"25","author":"Martignoni","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib43","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.pas.0000194298.19839.b4","article-title":"Angiomyolipoma with epithelial cysts (AMLEC): a distinct cystic variant of angiomyolipoma","volume":"30","author":"Fine","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/PAS.0b013e31817ed7a6","article-title":"Renal angiomyolipoma: clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association","volume":"33","author":"Aydin","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib45","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/modpathol.2013.72","article-title":"Epithelioid angiomyolipoma of the kidney: pathological features and clinical outcome in a series of consecutively resected tumors","volume":"26","author":"He","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib46","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/PAS.0b013e3181d90370","article-title":"Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy","volume":"34","author":"Brimo","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib47","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41391-020-0214-6","article-title":"Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer","volume":"23","author":"Gupta","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.humpath.2022.09.001_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2021.06.002","article-title":"Co-existence of ESC-RCC, EVT, and LOT as synchronous and metachronous tumors in six patients with multifocal neoplasia but without clinical features of tuberous sclerosis complex","volume":"116","author":"Lerma","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib49","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000001940","article-title":"Xanthomatous giant cell renal cell carcinoma: another morphologic form of TSC-associated renal cell carcinoma","author":"Argani","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib50","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000001955","article-title":"TSC\/MTOR-associated eosinophilic renal tumors exhibit a heterogeneous clinicopathologic spectrum: a targeted next-generation sequencing and gene expression profiling study","author":"Xia","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib51","series-title":"WHO classification of tumors editorial board. Urinary and male genital tumors","first-page":"56","article-title":"Other oncocytic tumors of the kidney","author":"Hartmann","year":"2022"},{"key":"10.1016\/j.humpath.2022.09.001_bib52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.eururo.2020.03.003","article-title":"Next-generation RNA sequencing-based biomarker characterization of chromophobe renal cell carcinoma and related oncocytic neoplasms","volume":"78","author":"Skala","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2022.09.001_bib53","article-title":"A contemporary guide to chromosomal copy number profiling in the diagnosis of renal cell carcinoma","author":"Gupta","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.humpath.2022.09.001_bib54","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.humpath.2021.09.010","article-title":"Morphologic overlap between low-grade oncocytic tumor and eosinophilic variant of chromophobe renal cell carcinoma","volume":"119","author":"Gupta","year":"2022","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib55","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/PAS.0000000000001170","article-title":"Somatic mutations of TSC2 or MTOR characterize a morphologically distinct subset of sporadic renal cell carcinoma with eosinophilic and vacuolated cytoplasm","volume":"43","author":"Chen","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib56","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00428-018-2456-4","article-title":"High-grade oncocytic renal tumor\": morphologic, immunohistochemical, and molecular genetic study of 14 cases","volume":"473","author":"He","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2022.09.001_bib57","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41379-021-00923-6","article-title":"Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC\/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases","volume":"35","author":"Farcas","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib58","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/PAP.0000000000000299","article-title":"Eosinophilic vacuolated tumor of the kidney: a review of evolving concepts in this novel subtype with additional insights from a case with MTOR mutation and concomitant chromosome 1 loss","volume":"28","author":"Kapur","year":"2021","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib59","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/his.13876","article-title":"High-grade oncocytic tumour (HOT) of kidney in a patient with tuberous sclerosis complex","volume":"75","author":"Trpkov","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.09.001_bib60","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/modpathol.2015.6","article-title":"TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype","volume":"28","author":"Hakimi","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib61","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.euf.2019.11.013","article-title":"Putative drivers of aggressiveness in TCEB1-mutant renal cell carcinoma: an emerging\u00a0entity with variable clinical course","volume":"7","author":"DiNatale","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.humpath.2022.09.001_bib62","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/PAS.0000000000001255","article-title":"Genetic underpinnings of renal cell carcinoma with leiomyomatous stroma","volume":"43","author":"Parilla","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib63","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00428-020-02910-9","article-title":"Renal cell carcinoma with leiomyomatous stroma in tuberous sclerosis complex: a distinct entity","volume":"478","author":"Gournay","year":"2021","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2022.09.001_bib64","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/modpathol.3880275","article-title":"Concurrent angiomyolipoma and renal cell neoplasia: a study of 36 cases","volume":"14","author":"Jimenez","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/genes12101585","article-title":"Renal cell carcinoma in tuberous sclerosis complex","volume":"12","author":"Henske","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.humpath.2022.09.001_bib66","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.humpath.2017.11.013","article-title":"Renal cell carcinoma with angioleiomyoma-like stroma and clear cell papillary renal cell carcinoma: exploring SDHB protein immunohistochemistry and the relationship to tuberous sclerosis complex","volume":"75","author":"Williamson","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib67","series-title":"WHO classification of tumors editorial board. Urinary and male genital tumors","first-page":"69","article-title":"Eosinophilic solid and cystic renal cell carcinoma","author":"Argani","year":"2022"},{"key":"10.1016\/j.humpath.2022.09.001_bib68","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/PAS.0000000000000838","article-title":"Eosinophilic solid and cystic renal cell carcinoma (ESC RCC): further morphologic and molecular characterization of ESC RCC as a distinct entity","volume":"41","author":"Trpkov","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib69","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/his.14663","article-title":"Eosinophilic solid and cystic renal cell carcinoma and renal cell carcinomas with TFEB alterations: a comparative study","volume":"81","author":"Lobo","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.09.001_bib70","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.humpath.2018.05.023","article-title":"Eosinophilic solid and cystic renal cell carcinoma mimicking epithelioid angiomyolipoma: series of 4 primary tumors and 2 metastases","volume":"80","author":"Tretiakova","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.09.001_bib71","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/his.13457","article-title":"Eosinophilic solid and cystic renal cell carcinomas have metastatic potential","volume":"72","author":"McKenney","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.09.001_bib72","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/PAS.0000000000001111","article-title":"Eosinophilic solid and cystic (ESC) renal cell carcinomas harbor TSC mutations: molecular analysis supports an expanding clinicopathologic spectrum","volume":"42","author":"Palsgrove","year":"2018","journal-title":"Am J Surg Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772200226X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772200226X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:41:01Z","timestamp":1758645661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004681772200226X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":72,"alternative-id":["S004681772200226X"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2022.09.001","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: cysts, angiomyolipomas, and renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2022.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}